BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2319145)

  • 1. Metronidazole resistant Bacteroides fragilis infection of a prosthetic hip joint.
    Hickey MM; Davies UM; Dave J; Vogler M; Wall RA
    J Infect; 1990 Mar; 20(2):129-33. PubMed ID: 2319145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteroides fragilis resistant to metronidazole after long-term therapy.
    Ingham HR; Eaton S; Venables CW; Adams PC
    Lancet; 1978 Jan; 1(8057):214. PubMed ID: 74641
    [No Abstract]   [Full Text] [Related]  

  • 3. Metronidazole treatment of Bacteroides fragilis infections.
    Melo JC; Raff MJ; Wunderlich HF; Chun CH; Summersgill JT; Varghese R
    Am J Med Sci; 1980; 280(3):143-9. PubMed ID: 7457495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteroides fragilis resistant to both metronidazole and imipenem.
    Lamothe F; Fijalkowski C; Malouin F; Bourgault AM; Delorme L
    J Antimicrob Chemother; 1986 Nov; 18(5):642-3. PubMed ID: 3468099
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacteroides fragilis endocarditis, bacteremia and other infections treated with oral or intravenous metronidazole.
    Galgiani JN; Busch DF; Brass C; Rumans LW; Mangels JI; Stevens DA
    Am J Med; 1978 Aug; 65(2):284-9. PubMed ID: 686012
    [No Abstract]   [Full Text] [Related]  

  • 7. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteraemia due to Bacteroides fragilis with reduced susceptibility to metronidazole.
    Elsaghier AA; Brazier JS; James EA
    J Antimicrob Chemother; 2003 Jun; 51(6):1436-7. PubMed ID: 12746378
    [No Abstract]   [Full Text] [Related]  

  • 9. Metronidazole treatment of liver abscess due to bacteroides fragilis.
    Bäck E; Hermanson J; Wickman M
    Scand J Infect Dis; 1978; 10(2):152-4. PubMed ID: 675165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Bacteroides fragilis resistance to metronidazole.
    Ghotaslou R; Bannazadeh Baghi H; Alizadeh N; Yekani M; Arbabi S; Memar MY
    Infect Genet Evol; 2018 Oct; 64():156-163. PubMed ID: 29936037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metronidazole-resistant Bacteroides fragilis wound infection.
    O'Donoghue MA; Potter J; Allen KD
    J Infect; 1992 Sep; 25(2):211-4. PubMed ID: 1431176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous metronidazole therapy for Bacteroides fragilis meningitis.
    Bryan CS; Huffman LJ; Del Bene VE; Sanders CV; Scalcini MC
    South Med J; 1979 Apr; 72(4):494-7. PubMed ID: 373128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteroides fragilis meningitis in a premature infant successfully treated with metronidazole.
    Webber SA; Tuohy P
    Pediatr Infect Dis J; 1988 Dec; 7(12):886-7. PubMed ID: 3211633
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacteroides fragilis meningitis successfully treated with metronidazole after a previous failure with thiamphenicol.
    Soriano F; Aguado JM; Tornero J; Fernandez-Guerrero ML; Gómez-Garcés JL
    J Clin Microbiol; 1986 Sep; 24(3):472-3. PubMed ID: 3760141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteroides fragilis resistant to the administration of clindamycin.
    Salaki JS; Black R; Tally FP; Kislak JW
    Am J Med; 1976 Mar; 60(3):426-8. PubMed ID: 1258888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced pathogenicity of susceptible strains of the Bacteroides fragilis group subjected to low doses of metronidazole.
    Diniz CG; Arantes RM; Cara DC; Lima FL; Nicoli JR; Carvalho MA; Farias LM
    Microbes Infect; 2003 Jan; 5(1):19-26. PubMed ID: 12593969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Metronidazole in experimental Bacteroides fragilis otitis media.
    Thore M; Sjöberg W; Burman LG; Holm SE
    Acta Otolaryngol; 1985; 99(1-2):60-6. PubMed ID: 3976396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined activity of metronidazole and gentamicin on Bacteroides fragilis in vivo and in vitro.
    Dijkmans BA; Vaishnav J; Mattie H
    J Antimicrob Chemother; 1985 Jan; 15(1):77-82. PubMed ID: 3882656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.